These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6377569)

  • 21. [Reduction of the size of a myocardial infarction using thrombolytic treatment. A myth impossible to dispel?].
    Sánchez de Posada I; Casariego Rosón J
    Rev Clin Esp; 1986 Nov; 179(7):378-82. PubMed ID: 3541081
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term use of indirect anticoagulants in patients with obliterating atherosclerosis of peripheral arteries].
    Khaĭne Kh; Norden K; Makh Kh; Shmidt Kh
    Kardiologiia; 1985 Sep; 25(9):61-3. PubMed ID: 3908781
    [No Abstract]   [Full Text] [Related]  

  • 23. [Further data on therapeutic fibrinolysis].
    Schmutzler R
    Helv Med Acta; 1963 Nov; 30(4):608-14. PubMed ID: 5878830
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract]   [Full Text] [Related]  

  • 27. A pilot study of streptokinase for acute cerebral infarction.
    Morris AD; Ritchie C; Grosset DG; Adams FG; Lees KR
    QJM; 1995 Oct; 88(10):727-31. PubMed ID: 7493170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombolytic therapy with a standardized system of dosage of purified streptokinase].
    Verstraete M; Vermylen J; Tytgat G
    Acta Chir Belg; 1966 Oct; 65(7):745-58. PubMed ID: 5972544
    [No Abstract]   [Full Text] [Related]  

  • 29. International Committee Communications. ICTH (International Committee on Thrombosis and Haemostasis). Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials. Eighth report 1986.
    Boissel JP
    Thromb Haemost; 1987 Jun; 57(3):361-71. PubMed ID: 3660335
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in coronary surgery: acute myocardial infarct and revascularization surgery].
    Concha Ruiz M
    Rev Esp Cardiol; 1984; 37 Suppl 1():16-25. PubMed ID: 6390586
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Turakhia MP; Murphy SA; Pinto TL; Antman EM; Giugliano RP; Cannon CP; Braunwald E; Gibson CM;
    Am J Cardiol; 2004 Dec; 94(11):1406-10. PubMed ID: 15566912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-lasting activation of the fibrinolytic system in blood and its clinical application].
    Bielawiec M
    Pol Tyg Lek; 1969 Jan; 24(2):63-6. PubMed ID: 4240415
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of noninvasive makers of coronary reperfusion in patients with acute myocardial infarction treated with thrombolysis].
    Corbalán R; Chávez E; Prieto JC; Castro P; Yovanovich J; Nazzal C; Cumsille F
    Rev Med Chil; 1996 Dec; 124(12):1423-30. PubMed ID: 9334475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the art--a journey through the world of antithrombotic therapy.
    Turpie AG
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():3-11. PubMed ID: 12232817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Temporary connection between coronary thrombosis and myocardial infarct].
    Emmrich P
    Z Gesamte Inn Med; 1970 Jan; 25(1):10-7. PubMed ID: 5522124
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of magnesium as antithrombotic therapy.
    Shechter M
    Wien Med Wochenschr; 2000; 150(15-16):343-7. PubMed ID: 11105330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.